WALSH DEINA H (Chief Financial Officer) purchased 7K shares of BONE BIOLOGICS CORP on the open market
Open‑market purchase worth $5.0K. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/7/2023ACC: 0001493152-23-031935
Officer· Chief Financial Officer
Since Jan 2022
+7K
Net shares
Net buyer
$5.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
7K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+300.00
Price / share
$0.70
Trade value
$210.00
% of position
New position
9/6/2023
0.00→300.00
Common Stock
Direct
Shares
+6.70K
Price / share
$0.71
Trade value
$4.76K
% of position
2233.3%
9/6/2023
300.00→7K
Total
Net shares
+7K
Net value
$4.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/6/2023 | P · Purchase | +300.00 | $0.70 | $210.00 | New position | 0.00 | 300.00 |
| Common Stock Direct | 9/6/2023 | P · Purchase | +6.70K | $0.71 | $4.76K | 2233.3% | 300.00 | 7K |
| Total | +7K | $4.97K | ||||||
Derivative Transactions0
No derivative transactions reported